Breaking News

Avara to Divest API Mfg. Site

PharmaVentures retained to sell the former AstraZeneca manufacturing plant in UK

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Advisory firm PharmaVentures has been appointed to sell a former AstraZeneca manufacturing site in Avonmouth, near Bristol, England. The active pharmaceutical ingredient (API) plant was bought in 2016 by Avara Pharma Services who, as part of the deal, took over the drug substance manufacture of the high-cholesterol drug Crestor for AstraZeneca on a contract basis. Restructuring of the Avara group has resulted in the current decision to divest the Avlon facility.   “We have had considerable...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters